FDA Inspection 1203784 — Jacek Mackiewicz, MD, PhD

Jacek Mackiewicz, MD, PhD — FEI 3026047473

The FDA completed an inspection of Jacek Mackiewicz, MD, PhD on April 28, 2023 in Poznan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 28, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Poznan (Poland)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate